The Crossroads of Special Operations

Sunday, May 16, 2021

Air Force Approves HIV Prevention Drug; Waiver Still Needed | Military.com

Must Read

The U.S. Air Force has approved the use of a medication designed to prevent HIV infection for pilots and aircrew, overriding an older policy that prohibited its use.

The service in September officially approved the use of the pre-exposure prophylaxis treatment (PrEP) medication, commonly known as Truvada, which helps reduce the risk of contracting the human immunodeficiency virus, the Air Force Surgeon General’s office recently told Military.com. Last year, Military.com profiled pilots whose careers were negatively affected because PrEP had not been authorized for them.

But there’s a catch: Pilots and aircrew who wish to use PrEP must apply for a waiver, said Air Force Surgeon General spokeswoman Angelica Lopez.

“As of September 2018, airmen in a flying status were able to request a waiver to use Truvada,” Lopez said in an email statement. “The waiver, once approved, will help ensure providers are monitoring the safety of the medication and aircrew compliance.”

Source: Air Force Approves HIV Prevention Drug; Waiver Still Needed | Military.com


- Advertisement -spot_img

- Advertisement -

Latest News

US Naval Special Warfare Operators strengthen maritime capabilities in Europe | DVIDS

US Naval Special Warfare Operators in Europe started the Trojan Footprint, which has utilized SEAL and Special Warfare Combatant-Craft...

- Advertisement -

More Articles Like This

- Advertisement -spot_img